DISCOUNT-ZERTIFIKAT - GSK PLC Share Price

Certificat

DE000HD1X637

Market Closed - BOERSE MUENCHEN 01:15:33 29/06/2024 am IST
16.6 EUR -0.18% Intraday chart for DISCOUNT-ZERTIFIKAT - GSK PLC
Current month-2.01%
1 month-1.78%
Date Price Change
28/24/28 16.6 -0.18%
27/24/27 16.63 -1.66%
26/24/26 16.91 +0.06%
25/24/25 16.9 0.00%
24/24/24 16.9 +0.24%

Real-time BOERSE MUENCHEN

Last update June 29, 2024 at 01:15 am IST

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying GSK PLC
IssuerLogo Issuer UniCredit UniCredit
WKN HD1X63
ISINDE000HD1X637
Date issued 17/01/2024
Cap 1,500 p
Last trading day 20/12/2024
Maturity 20/12/2024 (175 Days)
Parity 1 : 1
Emission price 15.85
Emission volume N/A
Payment day 31/12/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 7.936 %
Sideways yield 6.557 %
Sideways yield pa 13.68 %
Outperformance point 1,629 p
Break even 1,407.69 €
Highest since issue 16.99
Lowest since issue 15.83
Spread 0.01
Spread %0.06%
Distance Cap 29.5 p
Distance Cap %+1.93%
Max. earning 1.09
Max. earning % 6.557 %

Company Profile

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.
Sector
-
More about the company

Ratings for GSK plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: GSK plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
15.3 GBP
Average target price
20.28 GBP
Spread / Average Target
+32.62%
Consensus